Search

everythinglearnresearchcommunity

for

Search:↓

Post-COVID-19 hair loss is not linked to vitamin D or quality of life but is linked to hair graying.

Chemotherapy can cause significant but usually reversible hair loss, and managing it involves patient education and hair care strategies.

COVID-19 can cause temporary hair loss due to stress and inflammation.

The pull test and wash test are cheap, easy methods to diagnose hair loss.

Many medications can cause hair loss or excessive hair growth, which is usually reversible after stopping the drug.

Some patients lost hair after taking interferon alpha 2B, but it improved for some while still on the treatment and for others after stopping it.

Hair loss causes stress and affects mental health; treatment and support needed.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

Most patients with chronic hair shedding did not progress to permanent hair loss, and one showed improvement with treatment.

Chemotherapy often causes patterned hair loss, with some scalp areas more resistant to hair loss than others.

Higher BMI links to worse hair loss in Taiwanese men.

COVID-19 may cause hair loss and scalp pain due to inflammation and changes in hair follicle receptors, but these symptoms typically resolve in 2 to 4 months.

Hair loss in adult females in Makkah is often linked to iron-deficiency anemia and thyroid issues.

One supplement improved hair loss and quality faster and more effectively than the other in treating telogen effluvium.

Poor sleep during the pandemic may increase stress and worsen hair loss conditions.

COVID-19 and related stress may increase hair loss known as Telogen effluvium.

Telogen Effluvium is a common hair loss condition that can be short-term or long-lasting and is often caused by stress, illness, or nutritional issues.

Hair is thinner near the scalp in acute hair shedding conditions.

Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.

Hair usually grows back 1-3 months after treatment for anagen effluvium, and children with Loose Anagen Hair Syndrome often improve by adolescence.

COVID-19 may cause early hair loss similar to classic temporary hair loss, with further research needed.

Chemotherapy can cause rapid, extensive hair loss, with patterns varying between individuals.

Alfredo Rebora suggested a new, easier way to classify hair loss in Telogen Effluvium, adding a type possibly related to autoimmune diseases.

Proteoglycans are important for hair growth, and a specific treatment can help reduce hair loss.

A woman had hair loss, nail changes, and skin peeling after a COVID-19 infection, which got better on their own.

Hair loss can be an early sign of HIV infection.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

Alfredo Rebora suggests a simpler classification for hair loss and a new test for easier diagnosis.

Trichobiolight effectively treats hair loss with 82.5% success.

Hair loss lotion with specific ingredients effectively improves hair growth and thickness safely.